×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [5]
内容类型
期刊论文 [5]
发表日期
2021 [5]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共5条,第1-5条
帮助
限定条件
发表日期:2021
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
期刊论文
THORACIC CANCER, 2021
作者:
Shi, Yuequan
;
Fang, Jian
;
Zhou, Chengzhi
;
Liu, Anwen
;
Wang, Yan
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2022/01/25
advanced lung cancer
immune checkpoint inhibitors
immune-related adverse events
real-world data
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2021
作者:
Xu, Xiaoling
;
Wang, Ding
;
Chen, Wei
;
Li, Na
;
Suwinski, Rafal
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/02/14
Immune checkpoint inhibitor (ICI)
non-small cell lung cancer (NSCLC)
peripheral blood lymphocyte subsets
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden
期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:
Wang, Rong
;
Yang, Yuchen
;
Ye, Wei-Wu
;
Xiang, Jianxing
;
Chen, Songan
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2021/04/26
breast cancer
immunotherapy
biomarker
TMB
NGS
molecular monitoring
Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:
Jin, Ting
;
Zhang, Qun
;
Jin, Qi-Feng
;
Hua, Yong-Hong
;
Chen, Xiao-Zhong
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/01/25
Nasopharyngeal carcinoma
Metastasis
Chemotherapy
Recurrence
Anti-PD1 checkpoint inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace